Impact investments filled the capital gap to help fuel solutions to urgent issues, from racial equity to the COVID-19 pandemic.
BETHESDA, Md., April 21, 2021 /3BL Media/ – ImpactAssets, a $1.5 billion impact investing firm, today released 2020 figures showing a record 207 Custom Investments in private mission-driven businesses, impact funds and nonprofit organizations totaling $203 million. By comparison, the firm made a total of 152 Custom Investments worth $140 million in 2019, and 108 investments totaling $17.34 million in 2018.
Industry’s first publicly available, searchable resource of impact investing fund managers sees record number of applicants and assets, reflecting the innovation and exponential growth that the IA 50 has helped to spotlight over the past decade.
BETHESDA, Md., February 23, 2021 /3BL Media/—ImpactAssets has released the ImpactAssets 50 2021 (IA 50), a free online database for impact investors, family offices, financial advisors and institutional investors that features a diversified listing of private capital fund managers delivering social and environmental impact as well as financial returns.
Many families face an ongoing tension between the decision-maker “Patriarch” perspective and the younger “NextGen” perspective on how to approach investing and whether alpha should have primacy in investment decisions — with social, educational, justice, environmental, and other impact goals being served predominantly philanthropically — or if the two should always be approached as an integrated whole, regardless of asset class.
Interviewed by Cliff Feigenbaum, GreenMoney Journal
Welcome to the latest in the 'GreenMoney Interviews' series. Recently I spoke with Liesel Pritzker Simmons of Blue Haven Initiative, as part of our new "Millennials and Money" issue. Liesel oversees an impact investing portfolio structured to generate financial returns and address social and environmental challenges.
Dr. Jennifer Nuzzo and Shoshanah Brown join STS board to help address critical needs of the COVID-19 pandemic, evaluate new research, assess innovative testing and treatments and facilitate community engagement.
BETHESDA, Md., November 19, 2020 /3BL Media/ – As U.S.